Hannes Schill appointed to the Management Board of eCAPITAL AG
Hannes Schill is part of the eCAPITAL team already since 2014. After positions as an investment manager, director, partner and venture partner, he is again fulfilling an active partner role in the core team since May 2024.
Previous career stages include roles in corporate venture capital, renewable energy, finance and industry. Hannes Schill is a general manager by training, holding a BA degree in international business administration of the DHBW Stuttgart and an MBA degree of the Tuck School of Business (Dartmouth College, USA).
After three years on the operational side as CFO at a former portfolio company of eCAPITAL, I am back on the VC side as a Partner at eCAPITAL since May. It is a great honor for me to now be appointed to the management board of eCAPITAL. I am looking forward to continuing my work in such a great team of colleagues, searching and investing into visionary and impactful deeptech start-ups!
Hannes Schill, Managing Partner, eCAPITAL AG
With his experience in the VC business, his insights into the eCAPITAL structures and his popularity within the entire team, Hannes is an ideal addition to the board. I am pleased that Hannes is taking on the challenge of running a venture capital firm. All partners and myself will support him and the next generation in leading eCAPITAL successfully into the future!
Dr. Paul-Josef Patt, CEO, eCAPITAL AG
About eCAPITAL
Founded in 1999, eCAPITAL is an entrepreneur-led venture capital investor focusing on early- and growth-stage deep-tech companies with a positive impact on society. eCAPITAL is based in Germany and invests with its own funds with a total volume of over € 400 million in the areas of Sustainability, Enterprise Software, Cybersecurity, IoT and New Materials. In addition to financial resources, eCAPITAL offers its portfolio companies strategic support and access to an international network of entrepreneurs, scientists, investors and founders and was lead investor in various deep-tech companies such as sonnen, Novaled or Jedox, which were sold very successfully to international corporates or investors.